SAXAGLIPTIN AND METFORMIN
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SAXAGLIPTIN AND METFORMIN, covering 2023-07-31 to 2026-08-11. Get the full timeline:
Most recent: FDA Approved: SAXAGLIPTIN AND METFORMIN — Supplemental Application (Mylan Pharmaceuticals Inc.)